Karen Bush

发表

Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses

R. Webster, E. Govorkova, K. Bush, 2001, Antimicrobial Agents and Chemotherapy.

Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae

K. Bush, F. Tenover, Fred C. Tenover, 2008, Antimicrobial Agents and Chemotherapy.

CAU-1, a Subclass B3 Metallo-β-Lactamase of Low Substrate Affinity Encoded by an Ortholog Present in the Caulobacter crescentus Chromosome

Jean-Denis Docquier, Gianfranco Amicosante, Moreno Galleni, 2002, Antimicrobial Agents and Chemotherapy.

Tackling antibiotic resistance

Timothy R. Walsh, Alexander Tomasz, Christopher M. Thomas, 2011, Nature Reviews Microbiology.

Past and Present Perspectives on β-Lactamases

K. Bush, Karen Bush, 2018, Antimicrobial Agents and Chemotherapy.

Metallo-β-Lactamases: A Class Apart

K. Bush, Karen Bush, 1998 .

Crystal structures of the cadmium‐ and mercury‐substituted metallo‐β‐lactamase from Bacteroides fragilis

O. Herzberg, K. Bush, N. Concha, 1997, Protein science : a publication of the Protein Society.

Novel antibacterial agents for the treatment of serious Gram-positive infections.

K. Bush, M. Macielag, Karen Bush, 2003, Expert opinion on investigational drugs.

Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria.

K. Bush, J. Fisher, Jed F Fisher, 2011, Annual review of microbiology.

Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.

Annie Wong-Beringer, J. Quinn, J. Hindler, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae

K. Bush, F. Tenover, Fred C. Tenover, 2001, Antimicrobial Agents and Chemotherapy.

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy.

Robert Leary, Michael H. Miller, Arnold Louie, 2003, The Journal of clinical investigation.

Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis

O. Herzberg, K. Bush, N. Concha, 1996 .

The ABCD’s of β-lactamase nomenclature

K. Bush, Karen Bush, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Carbapenemases: the Versatile β-Lactamases

K. Bush, Karen Bush, Anne Marie Queenan, 2007, Clinical Microbiology Reviews.